Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities.

ABSTRACT: The transcriptomic classification of glioblastoma (GBM) has failed to predict survival and therapeutic vulnerabilities. A computational approach for unbiased identification of core biological traits of single cells and bulk tumors uncovered four tumor cell states and GBM subtypes distributed along neurodevelopmental and metabolic axes, classified as proliferative/progenitor, neuronal, mitochondrial and glycolytic/plurimetabolic. Each subtype was enriched with biologically coherent multiomic features. Mitochondrial GBM was associated with the most favorable clinical outcome. It relied exclusively on oxidative phosphorylation for energy production, whereas the glycolytic/plurimetabolic subtype was sustained by aerobic glycolysis and amino acid and lipid metabolism. Deletion of the glucose-pr

SUBMITTER: Garofano L 

PROVIDER: S-EPMC7935068 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature